My Portfolio

Fresenius Medical Care AG FMS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:00 PM EDT

20.90UNCH (UNCH)

Volume

5,818

20.90

+0.35 (+1.70%)

Volume

960,850

52 week range

20.02 - 29.07

Open20.79
Day High20.97
Day Low20.68
Prev Close20.55
52 Week High29.07
52 Week High Date06/12/25
52 Week Low20.02
52 Week Low Date05/05/26

Latest On Fresenius Medical Care AG

European stocks close higher as Iran war concerns weigh on sentimentMay 5, 2026CNBC.com
European markets finish higher as U.S. seeks end to Iran conflict March 25, 2026CNBC.com
Vertex passes key test in quest to treat kidney diseasesMarch 10, 2026CNBC.com
Spirits maker Diageo falls after slashing dividend, lowering profit outlookFebruary 25, 2026CNBC.com
European stocks finish higher as Trump's tariffs take effect at lower than expected 10%February 24, 2026CNBC.com
Berkshire Hathaway outperforms this week as tech stocks sinkFebruary 7, 2026CNBC.com
Europe markets fall; Sterling drops 1.2% against U.S. dollar amid fiscal jittersSeptember 2, 2025CNBC.com

Key Stats

Market Cap11.226B
Shares Out537.13M
10 Day Average Volume1.02M
Dividend0.86
Dividend Yield4.14%
Beta0.77

Latest On Fresenius Medical Care AG

European stocks close higher as Iran war concerns weigh on sentimentMay 5, 2026CNBC.com
European markets finish higher as U.S. seeks end to Iran conflict March 25, 2026CNBC.com
Vertex passes key test in quest to treat kidney diseasesMarch 10, 2026CNBC.com
Spirits maker Diageo falls after slashing dividend, lowering profit outlookFebruary 25, 2026CNBC.com
European stocks finish higher as Trump's tariffs take effect at lower than expected 10%February 24, 2026CNBC.com
Berkshire Hathaway outperforms this week as tech stocks sinkFebruary 7, 2026CNBC.com
Europe markets fall; Sterling drops 1.2% against U.S. dollar amid fiscal jittersSeptember 2, 2025CNBC.com

KEY STATS

Open20.79
Day High20.97
Day Low20.68
Prev Close20.55
52 Week High29.07
52 Week High Date06/12/25
52 Week Low20.02
52 Week Low Date05/05/26
Market Cap11.226B
Shares Out537.13M
10 Day Average Volume1.02M
Dividend0.86
Dividend Yield4.14%
Beta0.77

RATIOS/PROFITABILITY

EPS (TTM)1.90
P/E (TTM)11.02
Fwd P/E (NTM)13.01
EBITDA (TTM)4.413B
ROE (TTM)6.84%
Revenue (TTM)22.514B
Gross Margin (TTM)25.96%
Net Margin (TTM)6.03%
Debt To Equity (MRQ)83.29%

EVENTS

Earnings Date08/03/2026(est)
Ex Div Date05/22/2026
Div Amount0.8643
Split Date-
Split Factor-

Content From Our Affiliates

UBS Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)June 1, 2026TipRanks
Fresenius Medical launches first tranche of share buyback programMay 28, 2026TipRanks
Fresenius Medical Care AGM Backs Higher Dividend, New Buyback Mandate and U.S. Rollout of 5008X SystemMay 26, 2026TipRanks
Fresenius Medical announces EUR 1B share buyback programMay 26, 2026TipRanks
Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), Syndax Pharmaceuticals (SNDX) and Fresenius Medical Care (FMS)May 21, 2026TipRanks

Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research...

Martin Fischer

Chief Financial Officer, Member of the Management Board

Address

Else-Kroener-Strasse 1

Bad Homburg Vor Der Hohe

61352

Germany

https://www.freseniusmedicalcare.com/